
|Articles|May 27, 2004
FDA seeks input on prostate Ca clinical trial endpoints
FDA will hold a public workshop on prostate cancer as part of its ongoing series of meetings on oncology clinical trial endpoints.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants fast track designation to Enolen for localized prostate cancer
2
High PHI scores are linked to increased odds of significant prostate cancer
3
Trial to evaluate novel combination in BCG-unresponsive NMIBC
4
Dosing begins in trial of alpha radioligand therapy for mCRPC
5




















